Effect of pharmacological agents on human keratinocyte mitosis in vitro. I. Inhibition by adenine nucleotides.
D000225:Adenine / Q000494:pharmacology; D000227:Adenine Nucleotides / Q000494:pharmacology*; D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D003562:Cytidine / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D003864:Depression, Chemical; D006147:Guanine / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology; D006151:Guanosine / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D007288:Inosine / Q000494:pharmacology; D007292:Inosine Nucleotides / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects*; D012867:Skin / Q000166:cytology*; D013942:Thymine Nucleotides / Q000494:pharmacology; D014500:Uracil Nucleotides / Q000494:pharmacology
D000227:Adenine Nucleotides; D003597:Cytosine Nucleotides; D006150:Guanine Nucleotides; D007042:Hypoxanthines; D007292:Inosine Nucleotides; D013942:Thymine Nucleotides; D014500:Uracil Nucleotides; D006151:Guanosine; D000249:Adenosine Monophosphate; D007288:Inosine; D003562:Cytidine; D006147:Guanine; D000244:Adenosine Diphosphate; D003994:Bucladesine; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D006152:Cyclic GMP; D000225:Adenine; D000241:Adenosine